The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry.

[1]  D R Mani,et al.  Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. , 2009, Clinical chemistry.

[2]  M. Nieminen,et al.  Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. , 2009, Clinical chemistry.

[3]  Darryl B. Hardie,et al.  SISCAPA Peptide Enrichment on Magnetic Beads Using an In-line Bead Trap Device*S , 2009, Molecular & Cellular Proteomics.

[4]  J. Wetterö,et al.  Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[5]  P. Voorhees,et al.  A case of hook effect in the serum free light chain assay using the Olympus AU400e. , 2008, Clinical biochemistry.

[6]  Axel Scherer,et al.  Internally calibrated quantification of protein analytes in human serum by fluorescence immunoassays in disposable elastomeric microfluidic devices , 2008, Electrophoresis.

[7]  M. Sadílek,et al.  Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: application to newborn screening. , 2008, Clinical chemistry.

[8]  Andrew N Hoofnagle,et al.  Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. , 2008, Clinical chemistry.

[9]  N Leigh Anderson,et al.  High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. , 2008, Clinical chemistry.

[10]  Jianjun Yu,et al.  Humoral Response Profiling Reveals Pathways to Prostate Cancer Progression*S , 2008, Molecular & Cellular Proteomics.

[11]  J. Stephenson.  1000 Genomes Project , 2008 .

[12]  Tom Fiers,et al.  Pilot study for the standardization of insulin immunoassays with isotope dilution liquid chromatography/tandem mass spectrometry. , 2007, Clinical Chemistry.

[13]  Irene M Stratton,et al.  Comparison of 11 human insulin assays: implications for clinical investigation and research. , 2007, Clinical chemistry.

[14]  J. Hale,et al.  Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. , 2007, Analytical chemistry.

[15]  B. Davis,et al.  LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer , 2007 .

[16]  L. Ceriani,et al.  False-positive serum chromogranin A assay due to heterophile antibody interference. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[17]  W. Roberts,et al.  Performance characteristics of five automated CA 19-9 assays. , 2007, American journal of clinical pathology.

[18]  R. Sapin,et al.  Efficacy of a new blocker against anti-ruthenium antibody interference in the Elecsys free triiodothyronine assay , 2007, Clinical chemistry and laboratory medicine.

[19]  Rebekah L. Gundry,et al.  Investigation of an albumin‐enriched fraction of human serum and its albuminome , 2007, Proteomics. Clinical applications.

[20]  George G Klee,et al.  LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer. , 2007, Clinical chemistry.

[21]  W. Roberts,et al.  Performance characteristics of seven automated CA 15-3 assays. , 2006, American journal of clinical pathology.

[22]  Leigh Anderson,et al.  Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.

[23]  W. Roberts,et al.  Performance characteristics of seven automated CA 125 assays. , 2006, American journal of clinical pathology.

[24]  M. Fleseriu,et al.  Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of ‘hook effect’ , 2006, Journal of Neuro-Oncology.

[25]  Michael Pierce,et al.  Lectin immunoassays using antibody fragments to detect glycoforms of human chorionic gonadotropin secreted by choriocarcinoma cells. , 2005, Analytical biochemistry.

[26]  K. Resing,et al.  Proteomics strategies for protein identification , 2005, FEBS letters.

[27]  J. Rush,et al.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells , 2005, Nature Biotechnology.

[28]  W. Roberts,et al.  Performance characteristics of six third-generation assays for thyroid-stimulating hormone. , 2004, Clinical chemistry.

[29]  Werner Zolg,et al.  Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards , 2004, Proteomics.

[30]  Darryl B. Hardie,et al.  Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.

[31]  D. O'Kane,et al.  Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. , 2003, The Journal of clinical endocrinology and metabolism.

[32]  T. Annesley.  Ion suppression in mass spectrometry. , 2003, Clinical chemistry.

[33]  S. S. Levinson,et al.  Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[34]  F. Apple,et al.  False-positive AxSYM cardiac troponin I results in a 53-year-old woman. , 2002, Archives of pathology & laboratory medicine.

[35]  R. Sapin.  The Interference of Insulin Antibodies in Insulin Immunometric Assays , 2002, Clinical chemistry and laboratory medicine.

[36]  B. Morgan,et al.  Serum heterophile antibodies interfere with prostate specific antigen test and result in over treatment in a patient with prostate cancer. , 2001, The Journal of urology.

[37]  A M Ward,et al.  Prostate specific antigen: biology, biochemistry and available commercial assays , 2001, Annals of clinical biochemistry.

[38]  Y. Furuya,et al.  High dose hook effect in serum total and free prostate specific antigen in a patient with metastatic prostate cancer. , 2001, The Journal of urology.

[39]  D. Swallow,et al.  MUC1 gene polymorphism in the gastric carcinogenesis pathway , 2001, European Journal of Human Genetics.

[40]  R. Aebersold,et al.  Mass spectrometry in proteomics. , 2001, Chemical reviews.

[41]  D. Chace.  Mass spectrometry in the clinical laboratory. , 2001, Chemical reviews.

[42]  J. Bock,et al.  The new era of automated immunoassay. , 2000, American journal of clinical pathology.

[43]  L. Cole,et al.  False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations , 2000, The Lancet.

[44]  L. Rink,et al.  The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs. , 2000, Journal of immunological methods.

[45]  T. Jaskowski,et al.  Heterophile Antibodies to Bovine and Caprine Proteins Causing False-Positive Human Immunodeficiency Virus Type 1 and Other Enzyme-Linked Immunosorbent Assay Results , 1999, Clinical Diagnostic Laboratory Immunology.

[46]  L J Kricka,et al.  Human anti-animal antibody interferences in immunological assays. , 1999, Clinical chemistry.

[47]  J. Schlienger,et al.  Anti-thyrotropin antibody interference in thyrotropin assays. , 1998, Clinical chemistry.

[48]  P. Singer,et al.  Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. , 1998, The Journal of clinical endocrinology and metabolism.

[49]  S. Meijer,et al.  Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. , 1996, European journal of cancer.

[50]  J. Reinsberg.  Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay. , 1996, Clinical biochemistry.

[51]  B. Verrier,et al.  Biological and immunochemical characterization of recombinant human thyrotrophin. , 1995, Glycobiology.

[52]  G. Dale,et al.  Antibodies against biotinylated proteins are present in normal human serum. , 1994, The Journal of laboratory and clinical medicine.

[53]  J. Sheldon,et al.  Overestimation of Monoclonal Immunoglobulin by Immunochemical Methods , 1991, Annals of clinical biochemistry.

[54]  J. Fenn,et al.  Electrospray interface for liquid chromatographs and mass spectrometers. , 1985, Analytical chemistry.

[55]  S A BERSON,et al.  Immunoassay of endogenous plasma insulin in man. , 1996, The Journal of clinical investigation.